Leah Wright

Leah Wright

School of Chemical Engineering

Faculty of Sciences, Engineering and Technology

  • Journals

    Year Citation
    2023 Wright, L., Wignall, A., Jõemetsa, S., Joyce, P., & Prestidge, C. A. (2023). A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems. Drug Delivery and Translational Research, 13(4), 1088-1101.
    DOI Europe PMC1
    2022 Wright, L., Barnes, T. J., Joyce, P., & Prestidge, C. A. (2022). Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus. Pharmaceutics, 14(12), 2659.
    2022 Joyce, P., Wignall, A., Peressin, K., Wright, L., Williams, D. B., & Prestidge, C. A. (2022). Chitosan nanoparticles facilitate improved intestinal permeation and oral pharmacokinetics of the mast cell stabiliser cromoglycate. International Journal of Pharmaceutics, 612, 121382.
    DOI Scopus2 Europe PMC2
    2021 Wright, L., Joyce, P., Barnes, T. J., Lundmark, R., Bergström, C. A. S., Hubert, M., & Prestidge, C. A. (2021). A Comparison of Chitosan, Mesoporous Silica and Poly(lactic-co-glycolic) Acid Nanocarriers for Optimising Intestinal Uptake of Oral Protein Therapeutics. Journal of Pharmaceutical Sciences, 110(1), 217-227.
    DOI Scopus6 Europe PMC3
    2021 Wright, L., Joyce, P., Barnes, T. J., & Prestidge, C. A. (2021). Mimicking the Gastrointestinal Mucus Barrier: Laboratory-Based Approaches to Facilitate an Enhanced Understanding of Mucus Permeation. ACS Biomaterials Science & Engineering, 19 pages.
    DOI Scopus5
    2020 Wright, L., Barnes, T. J., & Prestidge, C. A. (2020). Oral delivery of protein-based therapeutics: Gastroprotective strategies, physiological barriers and in vitro permeability prediction. International Journal of Pharmaceutics, 585, 119488-1-119488-17.
    DOI Scopus17 Europe PMC3
    2018 Wright, L., Rao, S., Thomas, N., Boulos, R. A., & Prestidge, C. A. (2018). Ramizol<sup>®</sup> encapsulation into extended release PLGA micro- and nanoparticle systems for subcutaneous and intramuscular administration: <i>in vitro</i> and <i>in vivo</i> evaluation. Drug Development and Industrial Pharmacy, 44(9), 1451-1457.
    DOI Scopus14 WoS12 Europe PMC5

Connect With Me
External Profiles